Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maiko Iida

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bioscience, Biotechnology, and Biochemistry|December 2, 2017
Suppression of phenotype of Escherichia coli mutant defective in farnesyl diphosphate synthase by overexpression of gene for octaprenyl diphosphate synthaseHiroshi Takahashi, Yuta Aihara, Yukihiro Ogawa, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2015
Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of OnychomycosisYuji Tabata, Naomi Takei-Masuda, Natsuki Kubota, et al.
Protein Science : a Publication of the Protein Society|February 29, 2008
Crystal structure of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae reveals the binding mode of an inhibitorJun Saito, Mototsugu Yamada, Takashi Watanabe, et al.
Nature Chemistry|December 3, 2010
Total synthesis of the large non-ribosomal peptide polytheonamide BMasayuki Inoue, Naoki Shinohara, Shintaro Tanabe, et al.
Bioorganic & Medicinal Chemistry|January 1, 2025
Discovery of 2-(6-{[(1R,2R)-2-hydroxycyclohexyl]amino}-4,5-dimethylpyridazin-3-yl)-5-(trifluoromethyl)phenol (ASP0965): A potent, orally active and brain-penetrable NLRP3 inflammasome inhibitor with a novel scaffold for the treatment of α-synucleinopathyYusuke Inagaki, Takashi Kamikubo, Ikumi Kuriwaki, et al.
Bioorganic & Medicinal Chemistry|January 26, 2017
Design and synthesis of potent substrate-based inhibitors of the Trypanosoma cruzi dihydroorotate dehydrogenaseDaniel Ken Inaoka, Maiko Iida, Satoshi Hashimoto, et al.
Plos One|November 29, 2016
The Open Form Inducer Approach for Structure-Based Drug DesignDaniel Ken Inaoka, Maiko Iida, Toshiyuki Tabuchi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioscience, Biotechnology, and Biochemistry|December 2, 2017
Suppression of phenotype of Escherichia coli mutant defective in farnesyl diphosphate synthase by overexpression of gene for octaprenyl diphosphate synthaseHiroshi Takahashi, Yuta Aihara, Yukihiro Ogawa, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2015
Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of OnychomycosisYuji Tabata, Naomi Takei-Masuda, Natsuki Kubota, et al.
Protein Science : a Publication of the Protein Society|February 29, 2008
Crystal structure of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae reveals the binding mode of an inhibitorJun Saito, Mototsugu Yamada, Takashi Watanabe, et al.
Nature Chemistry|December 3, 2010
Total synthesis of the large non-ribosomal peptide polytheonamide BMasayuki Inoue, Naoki Shinohara, Shintaro Tanabe, et al.
Bioorganic & Medicinal Chemistry|January 1, 2025
Discovery of 2-(6-{[(1R,2R)-2-hydroxycyclohexyl]amino}-4,5-dimethylpyridazin-3-yl)-5-(trifluoromethyl)phenol (ASP0965): A potent, orally active and brain-penetrable NLRP3 inflammasome inhibitor with a novel scaffold for the treatment of α-synucleinopathyYusuke Inagaki, Takashi Kamikubo, Ikumi Kuriwaki, et al.
Bioorganic & Medicinal Chemistry|January 26, 2017
Design and synthesis of potent substrate-based inhibitors of the Trypanosoma cruzi dihydroorotate dehydrogenaseDaniel Ken Inaoka, Maiko Iida, Satoshi Hashimoto, et al.
Plos One|November 29, 2016
The Open Form Inducer Approach for Structure-Based Drug DesignDaniel Ken Inaoka, Maiko Iida, Toshiyuki Tabuchi, et al.
Pageof 2